Dr Rose Chesworth
The link between drug abuse and schizophrenia - cause or consequence?
Dr Fabian Kreilaus
The therapeutic evaluation of cannabinoids in the context of dementia and amyotrophic lateral sclerosis.
Dr Rossana Porto
Evaluation of new environmental factors in mouse models for schizophrenia.
Georgia Watt (PhD student)
Does cannabidiol (CBD) have therapeutic properties for the treatment of Alzheimer's disease?
Stefan Guerra (PhD student)
The evaluation of the validity of novel genetic mouse models for preclinical research into amyotrophic lateral sclerosis frontotemporal spectrum disorder.
Gabriela Visini (PhD student)
Anti-inflammatory properties of cannabidiol (CBD) - a new strategy for the treatment of dementia?
Madilyn Coles (MRes student)
Is there a role for low dose cannabidiol (CBD) treatment of Alzheimer's disease?
Sandip Ghimire (MRes student)
Do phytocannabinoids present novel therapeutic targets for the treatment of amyotrophic lateral scelerosis?
